Annual Summary of Disease Activity:
Disease Control Newsletter (DCN)
- DCN Home
- Annual Summary, 2021
- Annual Summary, 2020
- Annual Summary, 2019
- Annual Summary, 2018
- Annual Summary, 2017
- Annual Summary, 2016
- Annual Summary, 2015
- Annual Summary, 2014
- Annual Summary, 2013
- Annual Summary, 2012
- Annual Summary, 2011
- Annual Summary, 2010
- Annual Summary, 2009
- Annual Summary, 2008
- Annual Summary, 2007
- Annual Summary, 2006
- Annual Summary, 2005
- Annual Summary, 2004
- Annual Summary, 2003
- Annual Summary, 2002
- Annual Summary, 2001
- Annual Summary, 2000
- Annual Summary, 1999
- Annual Summary, 1998
- Annual Summary, 1997
Arboviral Disease, 2018
Endemic Mosquito-borne Arboviral Diseases
Historically, the primary arboviral encephalitides found in Minnesota have been La Crosse encephalitis, Western equine encephalitis (WEE), and West Nile virus (WNV) encephalitis, but in recent years other viruses, like Jamestown Canyon have emerged as significant causes of disease. While WNV and WEE are maintained in mosquito-to-bird transmission cycles involving several different species of each, La Crosse and Jamestown Canyon viruses use mammals instead of birds as part of their transmission cycles. WNV is established throughout Minnesota, and will probably be present in the state to some extent every year, whereas human cases of other diseases may occur more sporadically. Interpreting the effect of weather on arboviral transmission is complex, making it difficult to predict the number of people who will become infected in any given year.
In Minnesota, 63 WNV disease cases were reported in 2018, slightly more than the median number of cases per year (49) from 2012 to 2017, but considerably fewer than in record years. Thirty-five (56%) had neuroinvasive presentations including encephalitis or meningitis, and there were 2 deaths in older adults. The other 28 cases had West Nile fever. Seventy percent of the cases were male, and the median age was 62 years (range, 21 to 91). Thirty-nine (62%) cases were hospitalized. The majority of cases (95%) reported symptom onset in July, August, or September. Twenty-one asymptomatic WNV-positive blood donors were also identified in 2018. Risks for human WNV infection continue to be higher in central and western Minnesota where the primary mosquito vector, Culex tarsalis, is most abundant.
For the first time since 2009, there were no cases of La Crosse encephalitis reported. The disease, which primarily affects children, is transmitted through the bite of infected Aedes triseriatus (Eastern Tree Hole) mosquitoes, and is maintained in a cycle that includes mosquitoes and small mammals. Exposure to infected mosquitoes typically occurs in wooded or shaded areas inhabited by this species, especially in areas where water-holding containers (e.g., waste tires, buckets, or cans) that provide breeding habitats are abundant. Since 1985, 144 cases have been reported from 22 Minnesota counties, primarily in the southeastern part of the state. Many people who are infected have no apparent symptoms, but severe disease is more common in children. Most people report an illness onset during the typical arboviral season from mid-July through mid- September.
In 2018, 11 cases of Jamestown Canyon virus disease, a California group virus related to La Crosse, were reported. The virus is transmitted by Aedes mosquitoes, and the maintenance cycle in nature is thought to include deer and other large mammals. Much remains unknown about the clinical spectrum of Jamestown Canyon virus, but the typical presentation includes fever, and in more severe cases, meningitis or encephalitis. The virus is likely widespread in Minnesota. Cases were aged 21 to 82 years, with a median of 58 years, and 91% were male. Seven (64%) presented with neuroinvasive disease, including meningitis or encephalitis, and most were residents of counties in north central and northeastern Minnesota. Due to the mosquito vectors involved in the transmission cycle for this virus, disease onsets can occur from late spring through the early part of the fall.
Imported Mosquito-borne Arboviral Diseases
Dengue fever is one of the most frequently occurring mosquito-borne diseases worldwide, with an estimated 390 million infections, with nearly 100 million people experiencing symptomatic disease each year. Four serotypes of dengue virus are transmitted to humans through the bite of Aedes aegypti and Ae. albopictus mosquitoes. Dengue is considered endemic in more than 100 countries in tropical or subtropical regions around the world, and risk is widespread, especially where water-holding containers (e.g., waste tires, buckets, or cans) provide abundant mosquito breeding habitat.
In 2018, 13 cases were reported in Minnesota residents. The median case age was 38 years (range, 8 months to 69 years) and onset of symptoms occurred primarily in the latter half of the year from July through November. Twelve resided in the metropolitan area, and all infections were acquired abroad. Cases reported travel to many areas of the world, including to Haiti (7), Southeast Asia (3), Africa (2), and Central America (1).
Chikungunya virus is a mosquito-borne alphavirus found in Africa, Asia, and Europe. In late 2013, locally acquired cases appeared for the first time in the Americas on the Caribbean island of St. Martin, and the virus subsequently has spread throughout Central and South America. The virus is transmitted by the same Aedes spp. mosquitoes (Ae. aegypti and Ae. albopictus) that also transmit dengue and Zika viruses.
Unlike many other mosquito-borne viruses, most people who are infected with chikungunya develop symptoms. The most common symptoms are fever and joint pain, but patients may also experience headache, muscle aches, or rash. Symptoms usually begin 3-7 days after a person is bitten by an infected mosquito, and most recover within a week. Joint pain may persist for weeks to years after the initial illness.
In 2018, 7 cases were reported in Minnesota residents. The median case age was 38 (range, 30 to 76 years). Five resided in the metropolitan area and symptom onsets occurred all year, from February through November. All represented imported infections acquired abroad, and travel occurred to many areas of the world. Four traveled to Asia, two went to Africa, and one visited the Caribbean.
Zika virus is a mosquito-borne flavivirus that was initially discovered in 1947 in Uganda, and the first human cases were identified in 1952. Historically this virus occurred only sporadically in Africa and Asia, but it gained attention after it resulted in outbreaks in Micronesia in 2007 and French Polynesia in 2013-2014. In spring 2015, cases were reported from Brazil, representing the first time the virus had been found in the Americas. Since then, the virus has spread to most countries and territories in the Western Hemisphere, and infections during pregnancy have been associated with adverse fetal outcomes, including microcephaly. Zika has been shown to be transmitted perinatally as well as through sexual contact, a route of transmission that has never before been associated with a mosquitoborne virus. The mosquito vectors for humans are the same Aedes spp. mosquitoes (Ae. aegypti and Ae. albopictus) that transmit dengue virus and Chikungunya virus.
Although the outbreak in the Americas peaked in 2016, cases are still reported from around the region. The risk for infection persists throughout many areas of the world, but the ability to detect a new outbreak varies by country, and reporting of new outbreaks may be delayed several weeks to months. Since most people (up to 80%) that are infected with Zika do not develop symptoms, it is possible that many infections, and even small outbreaks, may go undetected.
In 2018, only 1 case of Zika virus disease was reported, and 1 asymptomatic blood donor was also identified. The case was a symptomatic, non-pregnant female who traveled to Asia, and the donor was a male with a recent history of travel to Mexico.
Endemic Tick-borne Arboviral Disease
Powassan virus (POW) is a tickborne flavivirus that includes a strain (lineage II or “deer tick virus”) that is transmitted by Ixodes scapularis. The virus can cause encephalitis or meningitis, and long-term sequelae occur in approximately half of those patients. Approximately 10-15% of cases are fatal. Since the first case in 2008, there have been cases every year except for 2014 and 2015, with a peak of 11 cases in 2011 (range, 1 to 11). Three cases of POW were reported in 2018. Two of the three were female, and ages ranged from 48 to 61 years. Although cases of non-neuroinvasive disease have been reported in previous years, all of the patients in 2018 presented with meningitis or encephalitis. Similar to other tick-borne diseases, the majority of patients report being exposed to ticks in north central Minnesota, and illness onsets follow a similar pattern as is seen for other tickborne diseases, with cases first experiencing symptoms between May and July. Based on findings from routine tick surveillance activities, the virus appears to be widely distributed in the same wooded parts of the state that are endemic to other pathogens transmitted by I. scapularis.
- For up to date information see>> Vector-borne Diseases
- Full issue>> Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2018